questionsmedicales.fr
Système nerveux
Système neuroendocrinien
Axe hypothalamohypophysaire
Axe hypothalamohypophysaire : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Axe hypothalamohypophysaire : Questions médicales les plus fréquentes",
"headline": "Axe hypothalamohypophysaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Axe hypothalamohypophysaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-14",
"dateModified": "2025-04-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Axe hypothalamohypophysaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Système neuroendocrinien",
"url": "https://questionsmedicales.fr/mesh/D009490",
"about": {
"@type": "MedicalCondition",
"name": "Système neuroendocrinien",
"code": {
"@type": "MedicalCode",
"code": "D009490",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.713"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Axe hypothalamo-hypophyso-gonadique",
"alternateName": "Hypothalamic-Pituitary-Gonadal Axis",
"url": "https://questionsmedicales.fr/mesh/D000094365",
"about": {
"@type": "MedicalCondition",
"name": "Axe hypothalamo-hypophyso-gonadique",
"code": {
"@type": "MedicalCode",
"code": "D000094365",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.713.357.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Éminence médiane",
"alternateName": "Median Eminence",
"url": "https://questionsmedicales.fr/mesh/D008473",
"about": {
"@type": "MedicalCondition",
"name": "Éminence médiane",
"code": {
"@type": "MedicalCode",
"code": "D008473",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.713.357.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hypophyse",
"alternateName": "Pituitary Gland",
"url": "https://questionsmedicales.fr/mesh/D010902",
"about": {
"@type": "MedicalCondition",
"name": "Hypophyse",
"code": {
"@type": "MedicalCode",
"code": "D010902",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.713.357.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adénohypophyse",
"alternateName": "Pituitary Gland, Anterior",
"url": "https://questionsmedicales.fr/mesh/D010903",
"about": {
"@type": "MedicalCondition",
"name": "Adénohypophyse",
"code": {
"@type": "MedicalCode",
"code": "D010903",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.713.357.750.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hypophyse intermédiaire",
"alternateName": "Pituitary Gland, Intermediate",
"url": "https://questionsmedicales.fr/mesh/D052716",
"about": {
"@type": "MedicalCondition",
"name": "Hypophyse intermédiaire",
"code": {
"@type": "MedicalCode",
"code": "D052716",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.713.357.750.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Neurohypophyse",
"alternateName": "Pituitary Gland, Posterior",
"url": "https://questionsmedicales.fr/mesh/D010904",
"about": {
"@type": "MedicalCondition",
"name": "Neurohypophyse",
"code": {
"@type": "MedicalCode",
"code": "D010904",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.713.357.750.875"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Axe hypothalamohypophysaire",
"alternateName": "Hypothalamo-Hypophyseal System",
"code": {
"@type": "MedicalCode",
"code": "D007030",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sabrina Chiloiro",
"url": "https://questionsmedicales.fr/author/Sabrina%20Chiloiro",
"affiliation": {
"@type": "Organization",
"name": "Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy."
}
},
{
"@type": "Person",
"name": "Laura De Marinis",
"url": "https://questionsmedicales.fr/author/Laura%20De%20Marinis",
"affiliation": {
"@type": "Organization",
"name": "Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy. Electronic address: Laura.DeMarinis@unicatt.it."
}
},
{
"@type": "Person",
"name": "Tommaso Tartaglione",
"url": "https://questionsmedicales.fr/author/Tommaso%20Tartaglione",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiology, Istituto Dermopatico dell'Immacolata, Rome and Università Cattolica del Sacro Cuore, Rome, Italy."
}
},
{
"@type": "Person",
"name": "Antonella Giampietro",
"url": "https://questionsmedicales.fr/author/Antonella%20Giampietro",
"affiliation": {
"@type": "Organization",
"name": "Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy."
}
},
{
"@type": "Person",
"name": "Antonio Bianchi",
"url": "https://questionsmedicales.fr/author/Antonio%20Bianchi",
"affiliation": {
"@type": "Organization",
"name": "Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Fibrous protein composite scaffolds (3D) for tissue regeneration: An in vitro study on skeletal muscle regeneration.",
"datePublished": "2022-06-26",
"url": "https://questionsmedicales.fr/article/35816880",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.colsurfb.2022.112656"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clearance of defective muscle stem cells by senolytics restores myogenesis in myotonic dystrophy type 1.",
"datePublished": "2023-07-19",
"url": "https://questionsmedicales.fr/article/37468473",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-023-39663-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human skeletal muscle organoids model fetal myogenesis and sustain uncommitted PAX7 myogenic progenitors.",
"datePublished": "2023-11-14",
"url": "https://questionsmedicales.fr/article/37963071",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7554/eLife.87081"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ascorbic acid reduces Ropivacaine-induced myotoxicity in cultured human osteoporotic skeletal muscle cells.",
"datePublished": "2023-07-15",
"url": "https://questionsmedicales.fr/article/37454045",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12891-023-06702-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "From cyclins to CDKIs: Cell cycle regulation of skeletal muscle stem cell quiescence and activation.",
"datePublished": "2022-08-02",
"url": "https://questionsmedicales.fr/article/35931143",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.yexcr.2022.113275"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009420"
},
{
"@type": "ListItem",
"position": 3,
"name": "Système neuroendocrinien",
"item": "https://questionsmedicales.fr/mesh/D009490"
},
{
"@type": "ListItem",
"position": 4,
"name": "Axe hypothalamohypophysaire",
"item": "https://questionsmedicales.fr/mesh/D007030"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Axe hypothalamohypophysaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Axe hypothalamohypophysaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Axe hypothalamohypophysaire",
"description": "Comment diagnostiquer un dysfonctionnement de l'axe ?\nQuels tests hormonaux sont utilisés ?\nQuels symptômes indiquent un problème hypothalamique ?\nQuand consulter un endocrinologue ?\nL'imagerie est-elle nécessaire pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D007030?mesh_terms=Muscle+Development&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Axe hypothalamohypophysaire",
"description": "Quels sont les symptômes d'un excès de prolactine ?\nComment se manifeste un déficit en cortisol ?\nQuels signes indiquent un hyperthyroïdisme ?\nQuels symptômes sont liés à l'hypopituitarisme ?\nComment reconnaître un syndrome de Cushing ?",
"url": "https://questionsmedicales.fr/mesh/D007030?mesh_terms=Muscle+Development&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Axe hypothalamohypophysaire",
"description": "Peut-on prévenir les troubles hormonaux ?\nComment éviter le stress sur l'axe hypothalamique ?\nLes examens réguliers sont-ils importants ?\nL'exercice physique aide-t-il l'axe hormonal ?\nFaut-il surveiller les antécédents familiaux ?",
"url": "https://questionsmedicales.fr/mesh/D007030?mesh_terms=Muscle+Development&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Axe hypothalamohypophysaire",
"description": "Quels traitements pour l'hyperprolactinémie ?\nComment traiter un déficit en hormone de croissance ?\nQuelles options pour l'hypothyroïdie ?\nComment gérer le syndrome de Cushing ?\nQuels médicaments pour l'hypopituitarisme ?",
"url": "https://questionsmedicales.fr/mesh/D007030?mesh_terms=Muscle+Development&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Axe hypothalamohypophysaire",
"description": "Quelles complications peuvent survenir avec l'hypopituitarisme ?\nQuels risques avec un excès de cortisol ?\nComment l'hyperthyroïdie affecte-t-elle le cœur ?\nQuelles sont les conséquences d'un traitement inapproprié ?\nQuels effets secondaires des médicaments hormonaux ?",
"url": "https://questionsmedicales.fr/mesh/D007030?mesh_terms=Muscle+Development&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Axe hypothalamohypophysaire",
"description": "Quels facteurs augmentent le risque d'hypopituitarisme ?\nLe stress est-il un facteur de risque ?\nL'âge influence-t-il les troubles hormonaux ?\nLes maladies auto-immunes sont-elles un risque ?\nY a-t-il un lien avec l'obésité ?",
"url": "https://questionsmedicales.fr/mesh/D007030?mesh_terms=Muscle+Development&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un dysfonctionnement de l'axe ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests hormonaux et des IRM peuvent aider à diagnostiquer les troubles."
}
},
{
"@type": "Question",
"name": "Quels tests hormonaux sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dosages de cortisol, TSH et prolactine sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème hypothalamique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de la température, de l'appétit ou des cycles menstruels peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Quand consulter un endocrinologue ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Si des symptômes hormonaux persistants apparaissent, une consultation est recommandée."
}
},
{
"@type": "Question",
"name": "L'imagerie est-elle nécessaire pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IRM peut révéler des anomalies structurelles de l'hypophyse."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un excès de prolactine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent galactorrhée, irrégularités menstruelles et infertilité."
}
},
{
"@type": "Question",
"name": "Comment se manifeste un déficit en cortisol ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il se manifeste par fatigue, perte de poids, et hypotension."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un hyperthyroïdisme ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Perte de poids, nervosité, et palpitations sont des signes d'hyperthyroïdisme."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'hypopituitarisme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, perte de libido et troubles de croissance peuvent indiquer l'hypopituitarisme."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un syndrome de Cushing ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Obésité centrale, vergetures et hypertension sont des signes du syndrome de Cushing."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles hormonaux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir certains troubles."
}
},
{
"@type": "Question",
"name": "Comment éviter le stress sur l'axe hypothalamique ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de gestion du stress comme la méditation peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans hormonaux réguliers peuvent aider à détecter des anomalies précocement."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il l'axe hormonal ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la régulation hormonale et la santé globale."
}
},
{
"@type": "Question",
"name": "Faut-il surveiller les antécédents familiaux ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles hormonaux peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Quels traitements pour l'hyperprolactinémie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les agonistes de la dopamine comme la cabergoline sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Comment traiter un déficit en hormone de croissance ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des injections d'hormone de croissance recombinante sont utilisées pour le traitement."
}
},
{
"@type": "Question",
"name": "Quelles options pour l'hypothyroïdie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La lévothyroxine est le traitement standard pour l'hypothyroïdie."
}
},
{
"@type": "Question",
"name": "Comment gérer le syndrome de Cushing ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure la chirurgie, la radiothérapie ou des médicaments."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour l'hypopituitarisme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des hormones de remplacement sont administrées selon les déficits identifiés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'hypopituitarisme ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent l'insuffisance surrénalienne et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels risques avec un excès de cortisol ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un excès de cortisol peut entraîner le diabète, l'hypertension et des infections."
}
},
{
"@type": "Question",
"name": "Comment l'hyperthyroïdie affecte-t-elle le cœur ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des arythmies et une hypertension, augmentant le risque cardiaque."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'un traitement inapproprié ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement inapproprié peut aggraver les symptômes et entraîner des complications graves."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des médicaments hormonaux ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des maux de tête et des changements d'humeur."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'hypopituitarisme ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de tumeurs hypophysaires ou de radiothérapie augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber l'axe hypothalamohypophysaire."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les troubles hormonaux ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de troubles hormonaux augmente avec l'âge."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent affecter l'axe hormonal."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien avec l'obésité ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité peut perturber la régulation hormonale et augmenter le risque de troubles."
}
}
]
}
]
}
The present study explores the differentiation of myoblasts in bioengineered 3D composite scaffolds containing keratin and gelatin. Based on the composition and rheological properties three different ...
Muscle stem cells, the engine of muscle repair, are affected in myotonic dystrophy type 1 (DM1); however, the underlying molecular mechanism and the impact on the disease severity are still elusive. H...
In vitro culture systems that structurally model human myogenesis and promote PAX7...
Osteoporosis is a worldwide health issue. Loss of bone mass is a potential risk factor for fragility fractures, and osteoporotic fractures place a considerable burden on society. Bone and muscle repre...
Primary human myoblasts and myotubes from healthy subjects, osteoarthritic and osteoporotic patients (OP) were cultured in the presence of Ropivacaine. In some experiments, ascorbic acid (AsA) was add...
A dose-dependent decrease of cell viability was observed after Ropivacaine exposure in both OP myoblasts and myotubes cultures, whereas those effects were not observed in the presence of Propofol, a g...
Our findings highlight the oxidative stress-mediated myotoxic effect of Ropivacaine on human skeletal muscle tissue cell cultures, and suggest treatment with AsA as valid strategy to mitigate its nega...
After extensive proliferation during development, the adult skeletal muscle cells remain outside the cell cycle, either as post-mitotic myofibers or as quiescent muscle stem cells (MuSCs, also known a...
Muscle-derived stem cells (MDSCs) contribute to the repair of injured muscles. However, the myogenicity of MDSCs generated from patients with Duchenne muscular dystrophy (DMD) relative to healthy indi...
A human DMD model was established using the stem cells prepared from muscle derived from patients with DMD (DMD-hMDSCs). The expression of myogenic lineage-specific markers in MDSCs was examined with ...
It was demonstrated that, compared with cells from healthy subjects, DMD-hMDSCs are primed to self-differentiate in growth-inducing medium (GM) and robustly differentiate into myotubes in differentiat...
The myogenesis activation in DMD-hMDSCs demonstrated in this study may provide novel mechanistic insights into DMD pathogenesis and potential therapies....
Injury to skeletal muscle through trauma, physical activity, or disease initiates a process called muscle regeneration. When injured myofibers undergo necrosis, muscle regeneration gives rise to myofi...
Skeletal muscle myogenesis represents one of the most intensively and extensively examined systems of cell differentiation, tissue formation, and regeneration. Muscle regeneration provides an in vivo ...
The prevalence of idiopathic scoliosis (IS) is 2-3% worldwide and is more common in girls. Estrogen receptors (ERs) is supposed to be related to sex differences and development of IS. Meanwhile, parav...
The AP-1 transcription factor, FBJ osteosarcoma oncogene (FOS), is induced in adult muscle satellite cells (SCs) within hours following muscle damage and is required for effective stem cell activation...
We established an inducible, FOS expression system to evaluate the impact of persistent FOS activity in muscle progenitor cells ex vivo. We performed various assays to measure cellular proliferation a...
Persistent FOS activity in primary muscle progenitor cells severely antagonizes their ability to differentiate and form myotubes within the first 2 weeks in culture. RNA-seq analysis revealed that ect...
Our results suggest that elevated FOS activity in recently activated muscle progenitor cells perturbs cellular differentiation by altering the 3D chromosome organization near critical pro-myogenic gen...